A Randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ t-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy
Jeffrey M. Jacobson, Hongying Wang, Rebeka Bordi, Lu Zheng, Barry H. Gross, Alan L. Landay, John Spritzler, Jean Pierre Routy, Constance Benson, Judith Aberg, Pablo Tebas, David W. Haas, Jennifer Tiu, Kristine Coughlin, Lynette Purdue, Rafick Pierre Sekaly
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A Randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ t-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy'. Together they form a unique fingerprint.